RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
-7.57%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.97B
AUM Growth
+$3.97B
Cap. Flow
+$166M
Cap. Flow %
4.17%
Top 10 Hldgs %
30.63%
Holding
141
New
5
Increased
76
Reduced
8
Closed
5

Top Buys

1
DXCM icon
DexCom
DXCM
$24.2M
2
IDXX icon
Idexx Laboratories
IDXX
$21.2M
3
CINC
CinCor Pharma, Inc. Common Stock
CINC
$18.1M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
$12.8M
5
PEN icon
Penumbra
PEN
$12.4M

Top Sells

1
HCA icon
HCA Healthcare
HCA
$18.8M
2
ISRG icon
Intuitive Surgical
ISRG
$18.6M
3
IMRX icon
Immuneering
IMRX
$17.6M
4
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$13M
5
XENT
Intersect ENT, Inc
XENT
$10.9M

Sector Composition

1 Healthcare 95.24%
2 Consumer Staples 1.53%
3 Industrials 0.67%
4 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PRTK
101
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5.13M 0.13%
1,726,637
+29,532
+2% +$87.7K
THRX
102
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$5.04M 0.13%
437,329
– –
INZY
103
DELISTED
Inozyme Pharma
INZY
$4.88M 0.12%
1,193,195
+324,729
+37% +$1.33M
ADAP
104
Adaptimmune Therapeutics
ADAP
$14.6M
$4.73M 0.12%
2,297,194
+81,606
+4% +$168K
FATE icon
105
Fate Therapeutics
FATE
$115M
$4.27M 0.11%
110,000
– –
SYRE icon
106
Spyre Therapeutics
SYRE
$1.01B
$4.17M 0.1%
1,811,425
+234,129
+15% +$538K
CGEN icon
107
Compugen
CGEN
$133M
$4.15M 0.1%
1,289,990
– –
EQRX
108
DELISTED
EQRx, Inc. Common Stock
EQRX
$4.13M 0.1%
+1,000,000
New +$4.13M
KNTE
109
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$3.88M 0.1%
344,146
+4,300
+1% +$48.4K
PHAS
110
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$3.45M 0.09%
2,613,825
+32,526
+1% +$42.9K
OKUR
111
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.7M
$3.36M 0.08%
1,143,185
– –
VIGL
112
DELISTED
Vigil Neuroscience
VIGL
$3.32M 0.08%
+471,958
New +$3.32M
CLDX icon
113
Celldex Therapeutics
CLDX
$1.55B
$3.32M 0.08%
+97,317
New +$3.32M
SPRB
114
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$3.26M 0.08%
1,622,689
– –
VINC
115
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$3.26M 0.08%
814,194
+4,999
+0.6% +$20K
EPIX icon
116
ESSA Pharma
EPIX
$11.3M
$3.24M 0.08%
524,944
+13,900
+3% +$85.9K
BLSA
117
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$3.05M 0.08%
309,000
– –
TPST icon
118
Tempest Therapeutics
TPST
$46.2M
$2.78M 0.07%
823,654
– –
FSTX
119
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$2.67M 0.07%
751,889
– –
PRLD icon
120
Prelude Therapeutics
PRLD
$69.6M
$2.55M 0.06%
368,959
– –
JYAC
121
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$2.03M 0.05%
206,200
– –
TLPH icon
122
Talphera
TLPH
$10.7M
$1.81M 0.05%
6,329,202
+3,300
+0.1% +$942
ELVN icon
123
Enliven Therapeutics
ELVN
$1.23B
$1.58M 0.04%
842,402
+100
+0% +$188
APLT icon
124
Applied Therapeutics
APLT
$72.7M
$1.48M 0.04%
701,680
– –
BCEL
125
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1.47M 0.04%
462,530
– –
2 3 4
5
6